Stephen M. Courtney

Free School Lane
Cambridge, ENG CB23RH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

'A very diadem of light': exhibitions in Victorian London, the Parliamentary light and the shaping of the Trinity House lighthouses.

'A very diadem of light': exhibitions in Victorian London, the Parliamentary light and the shaping of the Trinity House lighthouses.

Journal: British journal for the history of science

Published: April 25, 2017

Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.

Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.

Journal: Journal of medicinal chemistry

Published: January 16, 2015

Allosteric inhibition of the neuropeptidase neurolysin.

Allosteric inhibition of the neuropeptidase neurolysin.

Journal: The Journal of biological chemistry

Published: November 08, 2014

Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.

Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.

Journal: Blood

Published: October 08, 2014

Primary hyperparathyroidism with water clear cell content: the impact of histological diagnosis on clinical management and outcome.

Primary hyperparathyroidism with water clear cell content: the impact of histological diagnosis on clinical management and outcome.

Journal: Annals of the Royal College of Surgeons of England

Published: July 06, 2013

SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

Journal: ACS medicinal chemistry letters

Published: August 15, 2012

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Journal: ACS medicinal chemistry letters

Published: May 30, 2012

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.

Journal: Journal of medicinal chemistry

Published: January 10, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026